Taken together, these results demonstrate that the p66Shc-dependent decrease in intracellular ROS in CLL cells enhances NF-κB transcriptional activity, which in turn contributes to promote PD-L1 expression, thereby suppressing their ability to form ISs with T lymphocytes. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.